Jade Schiffman
Ophthalmology · Houston, TXNPI 1700888971
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,084 of the $10,010 with a category attached, or 60.8%. 17 manufacturers reported payments, led by AstraZeneca at 29.7% of the total. Reporting peaked in 2019 at $3,764 and has fallen 83.2% since, to $631 in 2025.
Across 119 payments — averaging $84.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Amgen$3K
- EMD Serono, Inc.$2K
- Harrow Eye, LLC$616
- Sanofi$359
- Novartis$293
- plus $1K from 11 others
Across 16 payments — averaging $31,480 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Puma Biotechnology, Inc.$313K
- Amgen$127K
- Novartis$64K
What the payments were for
- Consulting fees$2,24022%
- Travel & lodging$1,53815%
- Food & beverage$6,08461%
- Education$1481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $2,977 |
| Amgen(2 entities) | 27 | $2,813 |
| EMD Serono, Inc. | 25 | $1,918 |
| Harrow Eye, LLC | 18 | $616 |
| Sanofi | 6 | $359 |
| Novartis | 5 | $293 |
| Akcea Therapeutics, Inc. | 3 | $257 |
| Genentech USA, Inc. | 5 | $236 |
| Teva Pharmaceuticals USA, Inc. | 2 | $137 |
| Ablative Solutions, Inc. | 1 | $115 |
| Bausch & Lomb Americas Inc. | 4 | $74 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $70 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $38 |
| Thea Pharma Inc. | 1 | $20 |
| Argon Medical Devices, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,010 in reported general payments places this provider in the 85th percentile of 1,355 ophthalmology providers in Texas.
Other ophthalmology in Houston
- John MichelettiHouston$916K
- Christina WengHouston$676K
- Peter ChangHouston$656K
- Zaina Al-MohtasebHouston$636K
- Stephen SladeHouston$530K
- David BrownHouston$514K
- Shaheen KavoussiHouston$480K
- Elvia CansecoHouston$322K
- Bac NguyenHouston$319K
- Douglas KochHouston$308K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.